AccessBio, Top Search Ranking... Stock Price -3.61%
As of 12:30 PM on the 11th, Access Bio is trading at 29,400 KRW, down 3.61% from the previous day. This represents a 40.9% decline compared to August 19. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.
Over the past five days, individual investors have net sold 7,820 shares, while foreigners and institutions have net bought 9,498 shares and 651 shares, respectively.
On September 7, Access Bio became a market topic with the headline "Rising trend due to re-evaluation of COVID-19 antibody diagnostic kits."
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
